HL

Hongbo Lu

Healthcare Investor

Palo Alto, California

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $10,000,000.00

  • Max Investment:

    $50,000,000.00

  • Target Investment:

    $25,000,000.00

Education

Investments

Ronovo Surgical

Series B

Total Funding: $27M

Rgenta Therapeutics

Seed

Total Funding: $90M

Zenas BioPharma

Series B

Total Funding: $320M

Visirna Therapeutics

Seed

Total Funding: $60M

Avistone Pharmaceuticals

Series A

Total Funding: $200M

Ablaze Pharmaceuticals

Series A

Total Funding: $75M

Avedro

Series E

Total Funding: $150M

Turning Point Therapeutics

Series C

Total Funding: $130M

Work Experience

Vivo Capital

2020 - 2024

  • Managing Partner

    2020 - 2024

Lilly Asia Ventures

2017 - 2020

  • Managing Partner

    2017 - 2020

OrbiMed Advisors

2011 - 2016

  • Managing Director

    2011 - 2016

Piper Jaffray

2005 - 2011

  • Senior Equity Analyst, Principal,

    2005 - 2011

Zyomyx, Inc.

2000 - 2004

  • Technology Planning and Strategies Manager

    2000 - 2004